Andrej Dukát

9.7k total citations · 1 hit paper
61 papers, 1.1k citations indexed

About

Andrej Dukát is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrej Dukát has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 21 papers in Cardiology and Cardiovascular Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrej Dukát's work include Lipoproteins and Cardiovascular Health (16 papers), Blood Pressure and Hypertension Studies (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Andrej Dukát is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Blood Pressure and Hypertension Studies (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Andrej Dukát collaborates with scholars based in Slovakia, Czechia and United States. Andrej Dukát's co-authors include Martin Lefkowitz, Luís M. Ruilope, Michael Böhm, Yves Lacourcière, Jianjian Gong, Stanislav Oravec, Peter Sabaka, Ľudovít Gašpar, Akshay S. Desai and Victor Shi and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

Andrej Dukát

53 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

2010 448 citations Luís M. Ruilope, Andrej Dukát et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrej Dukát Slovakia	15	744	292	168	140	102	61	1.1k
Yuan‐Yuan Kang China	13	926 1.2×	392 1.3×	238 1.4×	114 0.8×	75 0.7×	48	1.4k
Juan Carlos Yugar‐Toledo Brazil	19	644 0.9×	261 0.9×	122 0.7×	63 0.5×	166 1.6×	78	1.0k
Wille Oigman Brazil	19	851 1.1×	341 1.2×	164 1.0×	80 0.6×	139 1.4×	69	1.3k
J NEUTEL United States	19	808 1.1×	329 1.1×	144 0.9×	67 0.5×	60 0.6×	61	1.0k
Franz H. Messerli United States	22	1.1k 1.5×	303 1.0×	333 2.0×	117 0.8×	82 0.8×	53	1.4k
R. Schmieder Germany	18	882 1.2×	390 1.3×	127 0.8×	113 0.8×	199 2.0×	59	1.3k
Joachim Schrader Germany	14	1.1k 1.5×	390 1.3×	133 0.8×	295 2.1×	82 0.8×	47	1.6k
Sylvie Gautier France	15	1.2k 1.6×	377 1.3×	303 1.8×	135 1.0×	202 2.0×	28	1.5k
Manolis S. Kallistratos Greece	17	768 1.0×	180 0.6×	195 1.2×	142 1.0×	98 1.0×	66	1.4k
Kei Endo Japan	24	653 0.9×	324 1.1×	417 2.5×	144 1.0×	239 2.3×	84	1.4k

Countries citing papers authored by Andrej Dukát

Since Specialization

Citations

This map shows the geographic impact of Andrej Dukát's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Dukát with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Dukát more than expected).

Fields of papers citing papers by Andrej Dukát

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrej Dukát. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Dukát. The network helps show where Andrej Dukát may publish in the future.

Co-authorship network of co-authors of Andrej Dukát

This figure shows the co-authorship network connecting the top 25 collaborators of Andrej Dukát. A scholar is included among the top collaborators of Andrej Dukát based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrej Dukát. Andrej Dukát is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Udelson, James E., Jan Bělohlávek, Andrej Dukát, et al.. (2025). Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure. JACC Heart Failure. 14(1). 102706–102706.

Dukát, Andrej, et al.. (2019). Management of diabetic patients with lower extremity peripheral arterial disease. Vnitřní lékařství. 65(4). 326–334.

Sabaka, Peter, et al.. (2017). The effects of body weight loss and gain on arterial hypertension control: an observational prospective study. European journal of medical research. 22(1). 43–43. 21 indexed citations

Trebatická, Jana, et al.. (2017). Cardiovascular Diseases, Depression Disorders and Potential Effects of Omega-3 Fatty Acids. Physiological Research. 66(3). 363–382. 38 indexed citations

Sabaka, Peter, Martin Čaprnda, Daniel Petrovič, et al.. (2017). Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women. Wiener klinische Wochenschrift. 129(21-22). 793–798. 34 indexed citations

Mogensen, Ulrik M., Lars Køber, Pardeep S. Jhund, et al.. (2017). Sacubitril/Valsartan Reduces Serum Uric Acid Concentration, An Independent Predictor of Adverse Outcomes in PARADIGM-HF. European Journal of Heart Failure. 20(3). 514–522. 35 indexed citations

Gašpar, Ľudovít, Peter Kružliak, Luı́s Rodrigo, et al.. (2016). Contribution of prostaglandin E1 treatment in patients with critical limb ischemia. 9(2). 2 indexed citations

Kružliak, Peter, Luı́s Rodrigo, J Gonsorčík, et al.. (2016). Effect of Low Dose Atorvastatin Therapy on Baroreflex Sensitivity in Hypertensives. High Blood Pressure & Cardiovascular Prevention. 23(2). 133–140. 5 indexed citations

Wawruch, Martin, et al.. (2015). The use of antiplatelet medication in hospitalised elderly patients. Bratislavské lekárske listy/Bratislava medical journal. 116(9). 533–538. 3 indexed citations

10.

Sabaka, Peter, et al.. (2015). Effect of hyperbaric oxygen on lipoprotein subfractions in diabetic patients.. PubMed. 42(5). 399–407. 4 indexed citations

11.

Kružliak, Peter, Ľudovít Gašpar, Miroslav Souček, et al.. (2015). Prognostic significance of dipping in older hypertensive patients. Blood Pressure. 24(2). 103–110. 13 indexed citations

12.

Sabaka, Peter, Peter Kružliak, Giovanni Cammarota, et al.. (2015). Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men. Lipids in Health and Disease. 14(1). 151–151. 10 indexed citations

13.

Gašpar, Ľudovít, Peter Kružliak, B Krahulec, et al.. (2015). Orthostatic hypotension in diabetic patients—10-year follow-up study. Journal of Diabetes and its Complications. 30(1). 67–71. 31 indexed citations

14.

Varga, Zoltán, et al.. (2013). Antikoagulačná terapia u geriatrických pacientov s fibriláciou predsiení. 27(1). 13–17.

15.

Sabaka, Peter, Peter Kružliak, Ľudovít Gašpar, et al.. (2013). Postprandial changes of lipoprotein profile: effect of abdominal obesity. Lipids in Health and Disease. 12(1). 179–179. 19 indexed citations

16.

Lietava, J., et al.. (2012). Homocysteine Slovakia study: study design and occurrence of hyperhomocysteinaemia and other risk factors. Bratislavské lekárske listy/Bratislava medical journal. 113(2). 80–86. 3 indexed citations

17.

Dukát, Andrej, et al.. (2011). Perorálne antidiabetiká a ich vplyv na endotelovú dysfunkciu. 25(1). 35–40.

18.

Lietava, J., et al.. (2010). Costs related to medical treatment for common cardiovascular risk factors.. PubMed. 111(10). 535–40. 4 indexed citations

19.

Ruilope, Luís M., Andrej Dukát, Michael Böhm, et al.. (2010). Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. The Lancet. 375(9722). 1255–1266. 448 indexed citations breakdown →

20.

Mitrović, Veselin, Roland Willenbrock, Marija Miric, et al.. (2003). Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. American Heart Journal. 145(3). E14–E14. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact